Avantor, Inc. (AVTR) Income Statement Analysis

See more : Marel hf. (MAREL.IC) Income Statement Analysis – Financial Results

Complete financial analysis of Avantor, Inc. (AVTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avantor, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.

You may be interested

Farmers & Merchants Bancorp (FMCB) Income Statement Analysis – Financial Results
Amit International Limited (AMITINT.BO) Income Statement Analysis – Financial Results
Information Planning CO., LTD. (3712.T) Income Statement Analysis – Financial Results
Huabao International Holdings Limited (HUIHY) Income Statement Analysis – Financial Results
Till Capital Corporation (TILCF) Income Statement Analysis – Financial Results

Avantor, Inc. (AVTR)

Industry: Chemicals - Specialty

Sector: Basic Materials

Website: https://www.avantorsciences.com

About Avantor, Inc.

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2001
Revenue	6.97B	7.51B	7.39B	6.39B	6.04B	5.86B	1.25B	691.30M	636.90M	4.91B
Cost of Revenue	4.60B	4.91B	4.88B	4.31B	4.12B	4.04B	814.60M	371.60M	374.70M	2.31B
Gross Profit	2.36B	2.60B	2.50B	2.08B	1.92B	1.82B	432.80M	319.70M	262.20M	2.60B
Gross Profit Ratio	33.93%	34.65%	33.88%	32.54%	31.80%	31.03%	34.70%	46.25%	41.17%	53.01%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	19.10M	21.90M	0.00
General & Administrative	0.00	0.00	0.00	1.37B	1.37B	1.41B	643.20M	309.80M	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	1.51B	1.47B	1.53B	1.37B	1.37B	1.41B	643.20M	309.80M	201.60M	1.47B
Other Expenses	0.00	-800.00K	10.60M	9.90M	2.50M	3.00M	3.40M	200.00K	-300.00K	0.00
Operating Expenses	1.66B	1.47B	1.53B	1.37B	1.37B	1.41B	643.20M	309.80M	201.90M	1.47B
Cost & Expenses	6.26B	6.38B	6.41B	5.69B	5.49B	5.45B	1.46B	681.40M	576.60M	3.78B
Interest Income	0.00	265.80M	229.30M	307.60M	440.00M	0.00	0.00	0.00	30.60M	0.00
Interest Expense	284.80M	265.80M	217.40M	307.60M	440.00M	523.80M	200.90M	80.30M	0.00	-265.80M
Depreciation & Amortization	402.30M	405.50M	379.20M	395.40M	398.90M	404.60M	99.20M	60.30M	60.70M	0.00
EBITDA	1.13B	1.53B	1.35B	765.30M	879.50M	814.60M	-91.20M	70.40M	121.10M	1.13B
EBITDA Ratio	16.19%	20.43%	18.44%	17.39%	15.78%	14.00%	-8.64%	10.18%	19.00%	23.02%
Operating Income	696.40M	1.13B	972.20M	706.80M	551.80M	413.50M	-210.40M	9.90M	60.30M	1.13B
Operating Income Ratio	10.00%	15.04%	13.16%	11.05%	9.14%	7.05%	-16.87%	1.43%	9.47%	23.02%
Total Other Income/Expenses	-285.90M	-279.10M	-219.20M	-644.50M	-511.20M	-527.30M	-249.80M	-80.50M	-30.50M	-279.10M
Income Before Tax	410.50M	851.10M	753.00M	62.30M	40.60M	-113.80M	-460.20M	-70.60M	29.80M	851.10M
Income Before Tax Ratio	5.89%	11.33%	10.19%	0.97%	0.67%	-1.94%	-36.89%	-10.21%	4.68%	17.34%
Income Tax Expense	89.40M	164.60M	180.40M	-54.30M	2.80M	-26.90M	-314.90M	10.10M	17.10M	-164.60M
Net Income	321.10M	686.50M	572.60M	116.60M	37.80M	-86.90M	-112.70M	-42.40M	21.60M	686.50M
Net Income Ratio	4.61%	9.14%	7.75%	1.82%	0.63%	-1.48%	-9.03%	-6.13%	3.39%	13.98%
EPS	0.48	1.02	0.86	0.20	-0.84	-0.18	-0.23	-0.09	0.04	1.05
EPS Diluted	0.47	1.01	0.85	0.20	-0.84	-0.18	-0.23	-0.09	0.04	1.01
Weighted Avg Shares Out	675.60M	650.90M	590.50M	576.30M	401.20M	496.50M	496.50M	491.30M	534.29M	650.90M
Weighted Avg Shares Out (Dil)	678.40M	679.40M	599.60M	583.40M	401.20M	496.50M	496.50M	491.30M	534.29M	679.40M

Avantor® to Participate in BofA Securities 2024 Health Care Conference

May 3, 2024prnewswire.com

RADNOR, Pa. , May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be...

Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down

April 29, 2024zacks.com

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.

Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript

April 26, 2024seekingalpha.com

Avantor Inc. (NYSE:AVTR ) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Christina Jones – Vice President-Investor Relations Michael Stubblefield – President and Chief Executive Officer Brent Jones – Executive Vice President and Chief Financial...

Avantor® Reports First Quarter 2024 Results

April 26, 2024prnewswire.com

Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% Net income of $60 million; Adjusted EBITDA of $283 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 Operating cash flow of $142 million; free cash flow...

Is a Surprise Coming for Avantor (AVTR) This Earnings Season?

April 25, 2024zacks.com

Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ELV or AVTR: Which Is the Better Value Stock Right Now?

April 25, 2024zacks.com

Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?

Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat

April 25, 2024zacks.com

Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.

BLCO vs. AVTR: Which Stock Is the Better Value Option?

April 8, 2024zacks.com

Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?

Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024

April 1, 2024prnewswire.com

RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results...